Reversal Dabigatran Anticoagulant Effect With Idarucizumab
Clinical trial NCT02815670 · COMPLETED
Trial details
- NCT number
- NCT02815670
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-07
- Primary completion
- 2019-10-19
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.